|
METAP2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.405500E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.361900E-03 |
| Normal-vs-Stage2 |
2.157900E-02 |
| Normal-vs-Stage3 |
1.422090E-03 |
| Normal-vs-Stage4 |
9.985400E-04 |
| Stage1-vs-Stage2 |
6.119000E-01 |
| Stage1-vs-Stage3 |
1.888950E-01 |
| Stage1-vs-Stage4 |
1.839790E-01 |
| Stage2-vs-Stage3 |
6.675600E-01 |
| Stage2-vs-Stage4 |
6.502400E-01 |
| Stage3-vs-Stage4 |
9.547200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.755660E-03 |
| Normal-vs-AfricanAmerican |
5.137000E-01 |
| Normal-vs-Asian |
9.320200E-03 |
| Caucasian-vs-AfricanAmerican |
2.130200E-01 |
| Caucasian-vs-Asian |
8.021800E-01 |
| AfricanAmerican-vs-Asian |
1.581160E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.160190E-03 |
| Normal-vs-Female |
3.220100E-03 |
| Male-vs-Female |
2.070400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.588020E-02 |
| Normal-vs-Age(41-60Yrs) |
2.035400E-03 |
| Normal-vs-Age(61-80Yrs) |
1.196700E-03 |
| Normal-vs-Age(81-100Yrs) |
2.854000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.411400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.318400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.101400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.032400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.709200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.595000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.678800E-01 |
| Classical-VS-Follicular |
1.024380E-01 |
| Classical-VS-Other |
8.589200E-01 |
| Classical-VS-Normal |
2.744400E-02 |
| Tall-VS-Follicular |
8.033400E-01 |
| Tall-VS-Other |
8.946800E-01 |
| Tall-VS-Normal |
1.056240E-02 |
| Follicular-VS-Other |
7.873800E-01 |
| Follicular-VS-Normal |
2.881900E-03 |
| Other-VS-Normal |
5.102000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.962660E-04 |
| Normal-vs-N1 |
9.94819999999841E-05 |
| N0-vs-N1 |
1.951990E-01 |
|
|
